245 related articles for article (PubMed ID: 32881478)
1. HMG-CoA Reductase Inhibitors as Drug Leads against
Hahn HJ; Abagyan R; Podust LM; Roy S; Ali IKM; Debnath A
ACS Chem Neurosci; 2020 Oct; 11(19):3089-3096. PubMed ID: 32881478
[TBL] [Abstract][Full Text] [Related]
2. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against
Hahn HJ; Debnath A
Pathogens; 2020 Aug; 9(9):. PubMed ID: 32842691
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
[TBL] [Abstract][Full Text] [Related]
5. Activity of Auranofin against Multiple Genotypes of
Escrig JI; Hahn HJ; Debnath A
ACS Chem Neurosci; 2020 Aug; 11(16):2464-2471. PubMed ID: 32392039
[TBL] [Abstract][Full Text] [Related]
6. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
[TBL] [Abstract][Full Text] [Related]
7. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Screen of Microbial Metabolites Identifies F
Yuan A; Fong H; Nguyen JV; Nguyen S; Norman P; Cullum R; Fenical W; Debnath A
ACS Infect Dis; 2023 Dec; 9(12):2622-2631. PubMed ID: 37943251
[TBL] [Abstract][Full Text] [Related]
9.
Debnath A; Nelson AT; Silva-Olivares A; Shibayama M; Siegel D; McKerrow JH
Front Microbiol; 2018; 9():414. PubMed ID: 29559968
[TBL] [Abstract][Full Text] [Related]
10. Fatal Primary Amebic Meningoencephalitis due to
Hong KW; Jeong JH; Byun JH; Hong SH; Ju JW; Bae IG
Yonsei Med J; 2023 Oct; 64(10):641-645. PubMed ID: 37727924
[TBL] [Abstract][Full Text] [Related]
11. The type 2 statins, cerivastatin, rosuvastatin and pitavastatin eliminate Naegleria fowleri at low concentrations and by induction of programmed cell death (PCD).
Rizo-Liendo A; Arberas-Jiménez I; Sifaoui I; Reyes-Batlle M; Piñero JE; Lorenzo-Morales J
Bioorg Chem; 2021 May; 110():104784. PubMed ID: 33684715
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Soltow SM; Brenner GM
Antimicrob Agents Chemother; 2007 Jan; 51(1):23-7. PubMed ID: 17060522
[TBL] [Abstract][Full Text] [Related]
13. Primary amebic meningoencephalitis: a review of Naegleria fowleri and analysis of successfully treated cases.
Hall AD; Kumar JE; Golba CE; Luckett KM; Bryant WK
Parasitol Res; 2024 Jan; 123(1):84. PubMed ID: 38182931
[TBL] [Abstract][Full Text] [Related]
14. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
Antimicrob Agents Chemother; 2003 Feb; 47(2):524-8. PubMed ID: 12543653
[TBL] [Abstract][Full Text] [Related]
15. Differential Growth Rates and
Russell AC; Kyle DE
Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
[TBL] [Abstract][Full Text] [Related]
16. Naegleria fowleri-associated meningoencephalitis in a cow in Southern Brazil-first molecular detection of N. fowleri in Brazil.
Henker LC; Lorenzett MP; Dos Santos DL; Virginio VG; Driemeier D; Rott MB; Pavarini SP
Parasitol Res; 2021 Aug; 120(8):2873-2879. PubMed ID: 34191130
[TBL] [Abstract][Full Text] [Related]
17. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
[TBL] [Abstract][Full Text] [Related]
18. The First Molecular Genotyping of
Soontrapa P; Jitmuang A; Ruenchit P; Tiewcharoen S; Sarasombath PT; Rattanabannakit C
Front Cell Infect Microbiol; 2022; 12():931546. PubMed ID: 35909963
[TBL] [Abstract][Full Text] [Related]
19. A case of primary amebic meningoencephalitis caused by Naegleria fowleri in Bangladesh.
Sazzad HMS; Luby SP; Sejvar J; Rahman M; Gurley ES; Hill V; Murphy JL; Roy S; Cope JR; Ali IKM
Parasitol Res; 2020 Jan; 119(1):339-344. PubMed ID: 31734864
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.
Sarink MJ; Tielens AGM; Verbon A; Sutak R; van Hellemond JJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
